Not available
Quote | Corium International Inc. (NASDAQ:CORI)
Last: | $ |
---|---|
Change Percent: | 0.24% |
Open: | $12.67 |
Close: | $12.68 |
High: | $12.745 |
Low: | $12.65 |
Volume: | 4,072,230 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Corium International Inc. (NASDAQ:CORI)
MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that ...
Agile Therapeutics, Inc. (AGRX) is a ~$160 million market capitalization biotechnology company that has had quite a wild ride over the last years. AGRX is a women's healthcare company that focuses on the development and commercialization of prescription contraceptive products for women. The ...
Message Board Posts | Corium International Inc. (NASDAQ:CORI)
Subject | By | Source | When |
---|---|---|---|
yesterday short pause and today it may // | PennyStock Alert | investorshub | 09/17/2019 3:43:01 PM |
Buy out by Gurnet Point: all shares | north40000 | investorshub | 10/11/2018 9:00:26 PM |
CORI buy 12.18 | stocktrademan | investorshub | 02/11/2018 4:55:54 PM |
Why are you buying here seems overbought to me | Rogerthat1 | investorshub | 06/02/2017 12:53:52 AM |
1% gain two days: sold soon after Open, | Frugivore | investorshub | 06/01/2017 2:53:38 PM |
News, Short Squeeze, Breakout and More Instantly...
Corium International Inc. Company Name:
CORI Stock Symbol:
NASDAQ Market:
Corium International Inc. Website:
MENLO PARK, Calif., Jan. 27, 2020 (GLOBE NEWSWIRE) -- Corium, Inc., a commercial-stage biopharmaceutical company leading the development of novel transdermal healthcare products that are intended to provide alternative treatment options for patients and their families, today announced that ...
MENLO PARK, Calif., April 02, 2019 (GLOBE NEWSWIRE) -- Corium, Inc. announced today that its Board of Directors has named Perry Sternberg as Chief Executive Officer. Mr. Sternberg is a senior pharmaceutical executive with commercial experience across a wide range of therapeutic areas ...
MENLO PARK, Calif., Dec. 17, 2018 (GLOBE NEWSWIRE) -- Corium International, Inc., a Delaware corporation (“Corium”, the “Issuer”, “we”, “us” or “our”), today announced that, as a result of its acquisition by Gurnet Point ...